Should slow coronary flow be considered as a coronary syndrome?

Jian-Jun Li1, Yong-Jian Wu, Xue-Wen Qin

  • 1Department of Cardiology, Center for Diagnosis and Treatment of Coronary Artery Disease, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People's Republic of China. lijnjn@yahoo.com.cn

Medical Hypotheses
|January 18, 2006
PubMed

Insights

Slow coronary flow, a condition without a clear cause, is a common finding in coronary angiography. Further research is needed to determine if this "slow coronary flow syndrome" is a distinct entity in coronary artery disease.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Diagnostic Imaging

Background:

  • The coronary slow flow phenomenon, first described in 1972, is characterized by reduced blood flow in coronary arteries without identifiable causes.
  • It is frequently observed during coronary angiography and must be differentiated from slow flow associated with other conditions like coronary reperfusion, spasm, or connective tissue disorders.

Purpose of the Study:

  • To investigate the nature of slow coronary flow in the absence of known etiologies.
  • To determine if slow coronary flow represents an independent entity or a variant of coronary artery disease.
  • To propose classifying this phenomenon as a distinct syndrome.

Main Methods:

  • Review of coronary angiography findings.
  • Differential diagnosis to exclude known causes of slow coronary flow.
  • Clinical and pathophysiological assessment (details not specified in the abstract).

Main Results:

  • Slow coronary flow is often detected in routine angiography.
  • It differs from slow flow seen after interventions or in conjunction with other cardiac/systemic diseases.
  • The etiology and clinical significance remain largely undetermined.

Conclusions:

  • Slow coronary flow without evident cause warrants further investigation.
  • It may represent a novel entity within coronary heart disease, potentially classifiable as 'slow coronary flow syndrome'.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...